BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15686888)

  • 21. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides.
    Tarko L; Supuran CT
    Bioorg Med Chem; 2007 Sep; 15(17):5666-71. PubMed ID: 17574422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
    Agrawal VK; Bano S; Supuran CT; Khadikar PV
    Eur J Med Chem; 2004 Jul; 39(7):593-600. PubMed ID: 15236839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and investigation of inhibition effect of fluorinated sulfonamide derivatives on carbonic anhydrase.
    Benfodda Z; Guillen F; Romestand B; Dahmani A; Blancou H
    Eur J Med Chem; 2010 Mar; 45(3):1225-9. PubMed ID: 20036446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of QSAR models based on combinations of genetic algorithm, stepwise multiple linear regression, and artificial neural network methods to predict Kd of some derivatives of aromatic sulfonamides as carbonic anhydrase II inhibitors.
    Maleki A; Daraei H; Alaei L; Faraji A
    Bioorg Khim; 2014; 40(1):70-84. PubMed ID: 25898725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quaternary ammonium substituted thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides: Potential membrane-impermeable inhibitors of carbonic anhydrase.
    May JA; Namil A; Chen HH; Dantanarayana AP; Dupré B; Liao JC
    Bioorg Med Chem; 2006 Mar; 14(6):2052-9. PubMed ID: 16297631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A physically interpretable quantum-theoretic QSAR for some carbonic anhydrase inhibitors with diverse aromatic rings, obtained by a new QSAR procedure.
    Clare BW; Supuran CT
    Bioorg Med Chem; 2005 Mar; 13(6):2197-211. PubMed ID: 15727872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases.
    Nasr G; Petit E; Supuran CT; Winum JY; Barboiu M
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6014-7. PubMed ID: 19796939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole-benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein.
    Entezari Heravi Y; Sereshti H; Saboury AA; Ghasemi J; Amirmostofian M; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):688-700. PubMed ID: 28317396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides--solution and crystallographic studies.
    Alterio V; De Simone G; Monti SM; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4201-7. PubMed ID: 17540563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.
    Jaiswal M; Khadikar PV; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3283-90. PubMed ID: 15149691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes.
    Kasimoğullari R; Bülbül M; Günhan H; Güleryüz H
    Bioorg Med Chem; 2009 May; 17(9):3295-301. PubMed ID: 19362844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
    Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.
    Carta F; Pothen B; Maresca A; Tiwari M; Singh V; Supuran CT
    Chem Biol Drug Des; 2009 Aug; 74(2):196-202. PubMed ID: 19549076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new synthesis of difluoromethanesulfonamides--a novel pharmacophore for carbonic anhydrase inhibition.
    Boyle NA; Chegwidden WR; Blackburn GM
    Org Biomol Chem; 2005 Jan; 3(2):222-4. PubMed ID: 15632962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
    Ghorab MM; Ragab FA; Hamed MM
    Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.
    Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM; Innocenti A; Supuran CT
    Bioorg Med Chem; 2007 Nov; 15(22):6975-84. PubMed ID: 17822907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
    Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B
    J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QSAR studies on carbonic anhydrase inhibitors: a case of ureido and thioureido derivatives of aromatic/heterocyclic sulfonamides.
    Agrawal VK; Sharma R; Khadikar PV
    Bioorg Med Chem; 2002 Sep; 10(9):2993-9. PubMed ID: 12110322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.